🔎 Trials Near Me

Hem › Akut myeloid leukemi › Utah › Salt Lake City

Kliniska studier för Akut myeloid leukemi i Salt Lake City, UT

17 studier för Akut myeloid leukemi söker deltagare vid platser i och runt Salt Lake City (inom ca 30 miles). Öppna en studie för att se vem som kan delta och hur du kontaktar studieteamet.

Officiell studietext (engelska)

Rekryterar du till en studie? Visa den högst upp på sidan – $99 i 30 dagar →

MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)

RekryterarFas 2
  • Huntsman Cancer Institute/University of Utah, Salt Lake City
  • George E Wahlen Department of Veterans Affairs Medical Center, Salt Lake City
Ålder 18 och äldre · Alla kön · Uppdaterad 5 okt. 2026 · NCT05564390

Ivosidenib as Post-HSCT Maintenance for AML

RekryterarFas 2
  • Huntsman Cancer Institute, University of Utah, Salt Lake City
Ålder 18 till 75 · Alla kön · Uppdaterad 5 okt. 2026 · NCT06707493

Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)

RekryterarFas 2
  • Huntsman Cancer Institute/University of Utah, Salt Lake City
Ålder 18 till 59 · Alla kön · Uppdaterad 28 sep. 2026 · NCT05554393

A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia (AML)

RekryterarFas 3
  • Intermountain Healthcare LDS Hospital, Salt Lake City
Ålder 18 och äldre · Alla kön · Uppdaterad 25 sep. 2026 · NCT06852222

Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)

RekryterarFas 2
  • Huntsman Cancer Institute/University of Utah, Salt Lake City
Ålder 18 och äldre · Alla kön · Uppdaterad 22 sep. 2026 · NCT06672146

Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)

RekryterarFas 2
  • Huntsman Cancer Institute/University of Utah, Salt Lake City
Ålder 18 till 59 · Alla kön · Uppdaterad 22 sep. 2026 · NCT05554406

Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)

RekryterarFas 2
  • Huntsman Cancer Institute/University of Utah, Salt Lake City
  • George E Wahlen Department of Veterans Affairs Medical Center, Salt Lake City
Ålder 18 och äldre · Alla kön · Uppdaterad 22 sep. 2026 · NCT06317649

A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations

RekryterarFas 3
  • Primary Children's Hospital, Salt Lake City
6 Months – 21 Years · Alla kön · Uppdaterad 17 sep. 2026 · NCT04293562

Evaluation of Two Dose Levels of Quizartinib as Maintenance in FLT3-ITD (+) Acute Myeloid Leukemia Patients in Complete Remission

RekryterarFas 2
  • Huntsman Cancer Institute, Salt Lake City
Ålder 18 och äldre · Alla kön · Uppdaterad 16 sep. 2026 · NCT06824168

(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis

RekryterarFas 2
  • Huntsman Cancer Institute - University of Utah Health, Salt Lake City
Ålder 18 och äldre · Alla kön · Uppdaterad 15 sep. 2026 · NCT04996875

Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML)

RekryterarFas 3
  • Primary Children's Hospital, Salt Lake City
29 Days – 21 Years · Alla kön · Uppdaterad 24 aug. 2026 · NCT05183035

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

RekryterarObservationsstudie
  • University of Utah, Salt Lake City
Alla åldrar · Alla kön · Uppdaterad 6 juli 2026 · NCT01351545

Study of Oral Administration of LP-118 in Patients With Relapsed or Refractory CLL, SLL, MDS, MDS/MPN, AML, CMML-2, MPN-BP, ALL, MF, NHL, RT, MM or T-PLL.

RekryterarFas 1
  • University of Utah, Salt Lake City
Ålder 13 och äldre · Alla kön · Uppdaterad 5 maj 2026 · NCT04771572

Study of Talazoparib in Combination With Chemotherapy in Relapsed Pediatric AML to Determine Safety and Efficacy

RekryterarFas 1
  • University of Utah, Salt Lake City
Upp till ålder 21 · Alla kön · Uppdaterad 22 apr. 2026 · NCT05101551

A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)

RekryterarFas 1/2
  • Huntsman Cancer Institute, Salt Lake City
  • Intermountain Healthcare, Salt Lake City
Ålder 12 och äldre · Alla kön · Uppdaterad 24 mars 2026 · NCT04988555

Akut myeloid leukemi-studier i andra städer

Andra studier i Salt Lake City

Från ClinicalTrials.gov, data hämtad 6 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.